Pfizer Inc
NYSE:PFE
Pfizer Inc
NYSE:PFE
Price:
25.735 USD
1.36%
Updated:
Apr 19, 2024
Pfizer Inc
Operating Income
Last
Value
3-Years CAGR
5-Years CAGR
|
Pfizer Inc
Operating Income Peer Comparison
Comparables:
JNJ
BMY
MRK
ZTS
LLY
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Pfizer Inc
NYSE:PFE
|
Operating Income
$12.9B
|
CAGR 3-Years
3%
|
CAGR 5-Years
8%
|
CAGR 10-Years
-3%
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Operating Income
$24.3B
|
CAGR 3-Years
6%
|
CAGR 5-Years
4%
|
CAGR 10-Years
4%
|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Operating Income
$10.8B
|
CAGR 3-Years
22%
|
CAGR 5-Years
7%
|
CAGR 10-Years
13%
|
|
|
Merck & Co Inc
NYSE:MRK
|
Operating Income
$4.1B
|
CAGR 3-Years
-28%
|
CAGR 5-Years
-19%
|
CAGR 10-Years
-7%
|
|
|
Zoetis Inc
NYSE:ZTS
|
Operating Income
$3.1B
|
CAGR 3-Years
11%
|
CAGR 5-Years
10%
|
CAGR 10-Years
14%
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Operating Income
$10.3B
|
CAGR 3-Years
15%
|
CAGR 5-Years
12%
|
CAGR 10-Years
6%
|
See Also
What is Pfizer Inc's Operating Income?
Operating Income
12.9B
USD
12.9B
USD
Based on the financial report for Dec 31, 2023, Pfizer Inc's Operating Income amounts to 12.9B USD.
What is Pfizer Inc's Operating Income growth rate?
Operating Income CAGR 10Y
-3%
-3%
Over the last year, the Operating Income growth was -67%. The average annual Operating Income growth rates for Pfizer Inc have been 3% over the past three years , 8% over the past five years , and -3% over the past ten years .
You don't have any saved screeners yet
